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http://dxObjective:Autophagy is an evolutionary conserved adaptive response that is believed to promote cell survival in
response to stressful stimuli via recycling of precursors derived from the degradation of endogenous cellular
components. The autophagic molecular machinery is controlled by a large family of autophagy-related genes
(ATGs) and downstream regulators. We sought to define the autophagy gene fingerprint associated with human
ischemia and reperfusion (IR) injury using an intraoperative model developed by Sellke and colleagues.
Methods: Right atrial appendages, collected from human hearts before and after cardioplegic arrest and after
reperfusion, were submitted for polymerase chain reaction (PCR) array, quantitative real-time PCR, and immu-
noblot analysis for autophagy proteins and their associated upstream regulators.
Results: Perioperative IR significantly upregulated 11 (13.1%) and downregulated 3 (3.6%) of 84 ATGs. Spe-
cifically, there were increases in the autophagy machinery components ATG4A, ATG4C, and ATG4D; tumor
necrosis factor–related apoptosis-inducing ligand, MAPK8 and BCL2L1; and chaperone-mediated autophagy
activity with increased heat shock protein (HSP) A8, HSP90AA1, and a-synuclein. Autophagy activity was con-
firmed through observations of higher LC3-I levels and an increase in the LC3-II/LC3-I ratio. Autophagy acti-
vation coincided with increased AMPK activation and decreased protein levels of the mammalian target of
rapamycin, the latter a key negative regulator of autophagy.
Conclusions: We provide the first human cardiac fingerprint of autophagy gene expression in response to IR.
These findings may inform on appropriate cell- and gene-based therapeutic approaches to limit aberrant cardiac
injury. (J Thorac Cardiovasc Surg 2014;147:1065-72)Supplemental material is available online.
Autophagy refers to a highly conserved cellular process for
the turnover of organelles and proteins that occurs in all
eukaryotic cells. It is generally activated as an adaptive re-
sponse to stressful conditions (nutrient deprivation, hyp-
oxia, and oxidative/genotoxic stress). Autophagy
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Sderived from the degradation of endogenous cellular com-
ponents. Although classically a mechanism of cell preserva-
tion, excessive and uncontrolled autophagy can promote
cell death.1 To date, autophagy has been implicated in
a number of fundamental biological processes, including
aging, immunity, development, tumorigenesis, cell death,
and differentiation.1-12 Loss of autophagy has been
implicated in various chronic diseases in which it is
believed to represent a compensatory mechanism to
maintain homeostasis during the early stages of disease
progression.1-12
In the heart, induction of autophagy is proposed to be pro-
tective by facilitating the removal of damaged proteins and
organelles and the recycling of proteins, glycogen, and fatty
acids, thus providing energy for myofibers during stress
and/or energy deprivation.1 Inasmuch as damaged mito-
chondria and cytochrome c release are potent triggers of ap-
optosis, the autophagic removal process is a critical
antiapoptotic mechanism.13 Indeed, Garcia and col-
leagues14 have recently reported impaired cardiac auto-
phagy in patients with postoperative atrial fibrillation.
Autophagy begins with the de novo formation of a cup-
shaped isolation double membrane (also called a phagophore
or preautophagosome) that engulfs a portion of cytoplasm.
The isolation membrane encloses to form a mature vesicle
(autophagosome) that subsequently fuses with a lysosome,
leading to the degradation of intra-autophagosomaldiovascular Surgery c Volume 147, Number 3 1065
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AMP ¼ adenosine monophosphate
AMPK ¼ adenosine monophosphate–activated
protein kinase
ATG ¼ autophagy-related gene
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apoptosis-inducing ligand
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Scomponents by lysosomal hydrolases.15 The autophagy
machinery is mainly regulated by autophagy-related genes
(ATGs) that have been evolutionarily conserved from
yeast to mammals.16,17 More than 30 ATGs have been
cloned2,3,8,10,12 and each critically guides induction of
the isolation membrane, engulfment of cytoplasm,
formation of the autophagic vesicles, and fusion with
lysosome.2,8,10,12,15
In the heart, baseline cardiac-specific loss of autophagy
results in a hypertrophic and dilated cardiomyopathy phe-
notype with poor response to pressure overload.18 During
acute stress, autophagy is triggered in response to cardiac
ischemia-reperfusion (IR) where it is generally considered
to be cardioprotective.19-21 Matsui and associates21 re-
ported, in cardiomyocytes during IR injury, expression of
the active form of the microtubule-associated protein light
chain 3 (LC3), an essential component for autophagosome
formation and a widely established marker of autophagy.
Adenosine monophosphate (AMP)-activated protein kinase
(AMPK)-dependent autophagy activation is reportedly pro-
tective during ischemia, although beclin-1–dependent acti-
vation appears to be detrimental during reperfusion.
Experimental coronary artery ligation rapidly upregulates
LC3 whereas the presence of autophagy inhibitor bafilomy-
cin A1 has been associated with an increased infarct size.
Together, these observations suggest an overall protective
role for autophagy.19 The presence of autophagic vacuoles,
cell death, and apoptosis has been demonstrated in1066 The Journal of Thoracic and Cardiovascular Surchronically ischemic human myocardium through ultra-
structural work.22 Interestingly, whereas mild ischemic in-
sults trigger autophagy, severe, protracted ischemia tips
the signaling balance to apoptotic and necrotic cell death.20
Finally, the nutrient-sensing molecule mammalian target of
rapamycin (mTor) is a critical regulator of autophagy in nu-
trient deficiency models and in ischemic injury.21,23
Despite the extensive interest in autophagy as a mediator
of the cardiac stress response, the majority of these data are
derived from in vitro cell culture preparations and animal
models. To the best of our knowledge, the autophagic
gene profile in human cardiac tissues that have been sub-
jected to IR has not been reported. In this report, we provide
for the first time the human autophagy gene fingerprint in
response to cardiac IR using a widely established intraoper-
ative model of atrial IR injury.24
MATERIALS AND METHODS
Study Population and Data Collection
The study protocol was reviewed and approved by the Research Ethics
Board of St Michael’s Hospital. Participation was voluntary and informed
consent obtained for all the cases. The original study cohort consisted of 9
patients. Another 7 individuals were enrolled to allow for confirmatory anal-
yses. We used the model of human intraoperative atrial IR before and after
cardiopulmonary bypass (CPB) validated by Dr Frank Sellke.24 Atrial sam-
ples (5 mm) were obtained from patients undergoing cardiac surgery with
crossclamp/cardioplegia (CP) and CPB for coronary artery bypass graft
(CABG) surgery. Pre-CP/CPB right atrial appendages were isolated using
a double purse-string suture method during venous cannulation. Two sepa-
rate superficial and deep purse-string sutures were placed at the right atrial
appendage, approximately 5-mm apart. The tip of the right atrial appendage
was harvested immediately (pre-CP/CPB) and the superficial purse-string
was used. The heart was arrested with an aortic root infusion of high-
potassium (27 mEq/L) blood CP solution. Blood CP was maintained with
a low potassium formulation at 4C. After weaning from bypass and a brief
period of reperfusion (5-15 minutes), the deep purse-string suture was tied
and the tissue between the 2 purse-string sutures harvested (post-CP/
CPB). Tissue samples were flash frozen immediately and stored at 80C.
Autophagy Polymerase Chain Reaction Array
Analysis and Quantitative Real-Time Polymerase
Chain Reaction
Initial transcript analyses were performed using samples from the orig-
inal cohort of 9 individuals. RNAwas extracted with a monophasic solution
of TRIzol (Invitrogen, Carlsbad, Calif) and the RT2 First StrandKit used for
cDNA synthesis (SA Biosciences, Hilden, Germany). Quantitative
real-time PCR (qPCR) was performed with RT2 qPCR Master Mixes in
a StepOne Plus Real-Time PCR System (Applied Biosystems, Foster
City, Calif). Gene expression profiles were generated with 96-well arrays
containing human ATGs (PAHS; 084, SA Biosciences) using the Human
Autophagy RT2 Profiler PCR Array (SA Biosciences) containing 84
ATGs in accordance with the manufacturer’s instructions. Threshold cycle
data were analyzed with the RT2 Profiler software (version 3.4; SA Biosci-
ences). The relative gene expression was normalized with multiple control
genes and the fold change in gene expression within post-CP/CPB samples
compared with those in the corresponding control pre-CPB samples. Genes
that had undergone significant upregulation or downregulation were identi-
fied from this initial work; and their temporal expression was mapped via
real-time PCR with samples from the original patient cohort (N ¼ 5-6)
and confirmed in those from an additional 7 patients.gery c March 2014
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Total protein, extracted with ice-cold RIPA buffer (Sigma Chemical Co,
St Louis, Mo) containing a protease inhibitor cocktail (Roche, Basel, Swit-
zerland), was quantified with the Bio-Rad Protein Assay Reagent. Protein
samples (40 mg) were separated by sodium dodecylsulfate–polyacrylamide
gel electrophoresis, transferred to nitrocellulose membranes, and probed
with antibodies from Cell Signaling (p62, caspase-3, LC3, mTor,
phospho-mTor, AMPK, and phosho-AMPK; all at a 1:1000 dilution) or
Millipore (glyceraldehyde 3-phosphate dehydrogenase, 1:4000). After in-
cubation with the appropriate horseradish peroxidase-associated secondary
antibodies (Santa Cruz Biotechnology, Santa Cruz, Calif), signals were
visualized with an enhanced chemiluminescence detection system (Amer-
sham Bioscience, Piscataway, NJ) and quantified by densitometry.
Statistical Analysis
Unless otherwise stated, data are presented as means  standard devia-
tion for number of samples. The Student t test was applied for comparison
of means of 2 groups.
RESULTS
Baseline Patient Characteristics and Intraoperative
Details
Baseline characteristics of the original patient cohort are
shown in Table 1. Information on the additional confirma-
tory patient cohort is provided in Table E1. All 9 of the orig-
inal patients were men, of whom 44.4% had hypertension,
55.6% had dyslipidemia, and 11.1% had diabetes. Cardiac
medications included angiotensin-converting enzyme in-
hibitors or angiotensin receptor blockers in 44.4% of sub-
jects, statin(s) in 88.9%, and b-blockers in 88.9%
preoperatively. Five patients underwent CABG surgery, 1TABLE 1. Baseline characteristics and intraoperative details
N ¼ 9
Age (y) 65.1  6.3
Male 100 (9)
Clinical history
Hypertension 44.4 (4)
Dyslipidemia 55.6 (5)
Diabetes 11.1 (1)
Smoking history 22.2 (2)
Heart failure 11.1 (1)
Medications
ACE inhibitor/ARB 44.4 (4)
Statin 88.9 (8)
Beta-blocker 88.9 (8)
Calcium channel blocker 11.1 (1)
Surgical procedure
CABG 55.6 (5)
AVR 11.1 (1)
AVR and CABG 33.3 (3)
Degree of ischemia
CPB (min) 96.2  26.2
Crossclamp/CP (min) 77.7  25.3
Reperfusion (min) 16.5  7.4
Data are presented as n (%) or mean  standard deviation. ACE inhibitor,
Angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; AVR,
aortic valve replacement; CABG, coronary artery bypass graft; CPB, cardiopulmo-
nary bypass; CP, cardioplegia.
The Journal of Thoracic and Carunderwent aortic valve replacement (AVR), and 3 patients
underwent combined CABG and AVR. Mean CPB, CP,
and reperfusion times were 96.2  26.2, 77.7  25.3, and
16.5  7.4 minutes, respectively, representing a mild and
acute IR insult.
IR Alters the Expression of ATGs in Human Atrial
Tissue
After IR, 30% (25/84) of the ATGs examined with the
Human Autophagy RT2 Profiler PCR Array demonstrated
at least a 1.5-fold change in expression. Real-time PCR
analyses confirmed that among the 25 ATGs identified, 11
(13.1% of the 84 genes studied) were significantly upregu-
lated and 3 (3.6% of the set of 84 genes) markedly downre-
gulated after IR (Table 2, Figures 1–4). Subsequent
real-time PCR analysis using samples from the confirma-
tory cohort indicated that 8 of the 10 genes that were exam-
ined in both groups had post-IR expression patterns that
mirrored those in the original cohort (Table E2).
IR Induces Expression of Autophagy Machinery in
Human Atrial Tissue
Expression of the ATG4 cysteine proteases ATG4A,
ATG4C, and ATG4D was significantly increased after IR
by PCR array and real-time PCR (Table 2, Table E2,
Figure 1, A, C, and D). There was also enhanced expression
of the ATG4 substrates, MAPLC3B (LC3B), g-aminobuty-
ric acid type A receptor–associated protein (GABARAP) 2
and GABARAP (Table 2; Table E2; Figure 1, E), the last ofTABLE 2. Select autophagy genes either upregulated or downregulated
by 1.5-fold after cardiopulmonary bypass/cardioplegia (CPB/CP)
(N ¼ 9)
Gene Fold change P value (before vs after CPB/CP)
Caspase-3 2.6 .02
EIF2AK3 2.5 .05
SNCA 2.5 .04
GABARAPL2 2.2 .02
DRAM2 2.0 .04
WIPI1 2.0 .05
ATG4D 2.0 .05
MAPK8 2.0 .05
HSP90AA1 1.9 .03
BCL2L1 1.8 .04
TNFSF10 1.7 .02
GAA 1.5 .04
mTOR 1.7 .02
ATG4B 1.8 .01
CPB, Cardiopulmonary bypass; CP, cardioplegia; EIF2AK3, eukaryotic initiation factor
2 A kinase; SNCA, a-synuclein; MAPK8, mitogen-activated protein kinase 8;
HSP90AA1, heat shock protein 90 kDa alpha (cytosolic), class A member 1; BCL2L1,
B-cell lymphocyte 2-like protein-1; TNFSF10, tumor necrosis factor; GAA, acid-alpha
glucosidase; mTOR, mammalian target of rapamycin; GABARAPL2, GABA(A) recep-
tor–associated protein-like 2; DRAM2, DNA-damage regulated autophagy modulator
2; WIPI1, WD repeat domain, phosphoinositide interacting 1; ATG4D, autophagy-
related 4D, cysteine peptidase; ATG4B, autophagy-related 4B, cysteine peptidase.
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FIGURE 1. Ischemia-reperfusion alters the expression of autophagy machinery genes in the human myocardium. Histograms represent quantitative real-
time polymerase chain reaction data for ATG4A (A), ATG4B (B), ATG4C (C), ATG4D (D), GABARAPL2 (E), and EIF2AK3 (F). GAPDH was the
reference gene. n ¼ 6 per group. *P< .05, ** P< .01 versus data from pre-cardiopulmonary bypass/cardioplegia samples. GAPDH, Glyceraldehyde
3-phosphate dehydrogenase; CPB, cardiopulmonary bypass; ATG, autophagy-related gene; mRNA, messenger RNA.
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amine (PE), a key step in autophagosome biogenesis. In
contrast, ATG4B, responsible for ATG8 cleavage and
ATG8-PE complex deconjugation and ATG8 membrane re-
lease, was downregulated (Table 2; Figure 1, B). Autophagy
activation was associated with increased protein kinase
R–like eukaryotic initiation factor 2 A kinase (EIF2AK3)
expression indicating endoplasmic reticulum stress after
IR injury (Table 2; Figure 1, F).IR Induces Expression of Autophagy and Apoptosis
Markers
We report antiapoptotic signaling with increased expres-
sion of tumor necrosis factor–related apoptosis-inducing
ligand (TNFSF10/TRAIL), mitogen-activated protein ki-
nase 8 (MAPK8), and B-cell lymphocyte 2 (Bcl-2)-like
protein-1 (BCl2L1/Bcl-xL) (Table 2; Figure 2, A and B),
and decreased BAK1 expression (Figure 2, D). Transcript
and protein levels of caspase-3 were increased (Table 2;
Figure 2, E). Thus, autophagy-related antiapoptotic and
proapoptotic genes are expressed concurrently.IR Induces Chaperone-Mediated Autophagy in
Human Atrial Tissues
Chaperone-mediated autophagic activity is the only type
of autophagy capable of selective targeting of autophagy
substrates. We observed increased expression of the molec-
ular chaperones heat shock protein (HSP) A8 and
HSP90AA1 after IR injury (Table 2; Figure 3, A).1068 The Journal of Thoracic and Cardiovascular SurFurthermore, a-synuclein (SNCA), which serves to inte-
grate presynaptic signaling, membrane trafficking, and pro-
mote chaperone-mediated autophagic, was also upregulated
after IR injury (Table 2; Figure 3, B).IR Induces AMPK-mTOR Axis in Human Atrial
Tissue
IR was associated with increases in AMPK activation
(Figure 4, A) and suppressed transcript and protein levels
of mTor, a potent inhibitor of autophagy (Table 2;
Figure 4, B and C). There was a concomitant dramatic in-
crease in LC3-I protein levels with significant elevations
in LC3-II/LC3-I ratio, indicating autophagy activity
(Figure 4, D). Glycogen degrading lysosomal hydrolase
acid-alpha glucosidase (GAA) gene expression was
decreased after IR (Figure 4, E). Western blot analysis
revealed no significant change in p62 expression after IR
injury (Figure 4, F).DISCUSSION
This is the first report demonstrating the global pattern of
autophagy gene activation in human myocardium after
acute IR injury. The key findings are (1) increased ATG
gene expression; (2) dramatically increased autophagic ac-
tivity as evidenced by a shift in the LC3-II/LC3-I ratio; and
(3) activation of known upstream AMPK signaling and as-
sociated loss of mTor inhibition, suggesting a regulatory
mechanism.gery c March 2014
FIGURE 2. Ischemia-reperfusion alters the expression of coregulators of autophagy and apoptosis in the human myocardium. Histograms represent quanti-
tative real-time polymerase chain reaction data for TNFSF10 (A), BCL2L1 (B), caspase-3 (C), and BAK (D). GAPDH acted as the reference gene. E, Western
blot and semiquantitative analysis of caspase-3 levels. GAPDH was the loading reference protein. n ¼ 6 per group. *P<.05, **P<.01 versus data from pre-
cardiopulmonary bypass/cardioplegia samples. GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; CPB, cardiopulmonary bypass; TNFSF, tumor necrosis
factor; BCL2L1, B-cell lymphocyte 2-like protein-1; BAK, B-cell lymphocyte 2 homologous antagonist/killer; mRNA, messenger RNA; AU, arbitrary units.
Singh et al Evolving Technology/Basic ScienceWe used a widely validated model of human atrial car-
diac ischemia and reperfusion during CPB with CP arrest,
followed by reperfusion. Given the variability in studiesFIGURE 3. Ischemia-reperfusion induces chaperone-mediated autophagy
in the human myocardium. Histograms represent quantitative real-time poly-
merase chain reaction data for HSPA8 (A) and SNCA (B). GAPDH was
the reference gene. n ¼ 6 per group. *P < .05 versus data from
pre-cardiopulmonary bypass/cardioplegia samples. GAPDH, Glyceralde-
hyde 3-phosphate dehydrogenase; CPB, cardiopulmonary bypass; SNCA,
a-synuclein; HSPA8, heat shock 70 kDa protein 8; mRNA, messenger RNA.
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each patient acted as his or her own control in determination
of differential gene expression. The degree of injury has
previously been shown to be sufficient to trigger cardio-
myocyte injury and acute cardioprotective responses by
our group and others.24,25
In this report, we demonstrate increased expression of
several genes of the autophagy machinery. Using a PCR ar-
ray system to study samples from 9 patients, we identified
25 ATGs that were either upregulated or downregulated at
least 1.5-fold after IR insult. Subsequent real-time PCR
analysis in these samples and those from an additional 7 in-
dividuals confirmed that the expression of key ATGs is as-
sociated with IR injury. The central step in autophagosome
formation is cleavage of ATG8 and conjugation to PE for
autophagosome membrane extension, fusion, and the even-
tual enclosure of the membrane for vesicle formation.26 The
ATG4 homologs, which were upregulated after IR injury,
are necessary for ATG8 cleavage, protein targeting to mem-
branes/vacuoles, protein transport, and for proteasediovascular Surgery c Volume 147, Number 3 1069
FIGURE 4. Ischemia-reperfusion is associated with AMPK-mediated reductions in mTor activation and increased autophagy in the human myocardium.
Atrial samples were submitted for either Western blot analysis or qPCR. Representative immunoblots and semiquantitative results are shown for AMPK/p-
AMPK (A), mTOR (C), LC3 (D), and p62 (F). qPCR results are shown for mTOR (B) and GAA (E). GAPDH was the reference gene/protein. n ¼ 5 per
group. *P<.05, **P<.01 versus data from pre-cardiopulmonary bypass/cardioplegia samples. GAPDH, Glyceraldehyde 3-phosphate dehydrogenase;
CPB, cardiopulmonary bypass; AMPK, adenosine monophosphate–activated protein kinase; mTOR, mammalian target of rapamycin; p-mTOR,
phospho-mammalian target of rapamycin; LC, light chain; p-AMPK, phosphorylated adenosinemonophosphate–activated protein kinase;AU, arbitrary units.
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in LC3-II generation.28 The endoplasmic reticulum mem-
brane–associated protein, EIF2AK3, is activated by mis-
folded proteins, a signal of endoplasmic reticulum stress,
which then acts as a strong inducer of autophagy.29 We
also observed the higher expression of SNCA demonstrat-
ing activation of the chaperone-mediated autophagic path-
way, which selectively degrades cytosolic proteins
containing a targeting motif recognized by a cytosolic chap-
erone complex.
Although the role of autophagy in promoting survival is
widely established, there has been some debate as to whether
autophagy may also contribute to cell death. We found
significantly increased levels of MAPK8, TNFSF10, and
antiapoptotic BCl2L1 as well as decreases in proapoptotic1070 The Journal of Thoracic and Cardiovascular SurBAK1 expression. It is known that TNFSF10/TRAIL induces
cytoprotective MAPK8/JNK-dependent autophagy.30 Apo-
ptosis activation has previously been demonstrated in this
human IRmodel31 and, consistent with this, our data confirm
increased caspase-3 expression. Accordingly, we provide
evidence of both proapoptotic and antiapoptotic signaling
in acute human IR injury. Whether autophagy is protective
or proapoptotic remains to be determined and may depend
on the balance of contribution during ischemia versus
reperfusion.
We found activation of the AMPK-mTor signaling axis,
a critical regulator of the balance between survival
and apoptotic signals, mitochondrial bioenergetics, auto-
phagy, and inflammation. Consistent with our findings, pre-
vious studies have shown that ischemia activates thegery c March 2014
Singh et al Evolving Technology/Basic Scienceenergy-sensing kinase AMPK, a negative regulator of
mTOR, the latter being a potent inhibitor of autophagy.32
This was associated with a marked increase in the expres-
sion of LC3 and in the conversion of LC3-I to LC3-II,
a key step in autophagosome formation.33 Western blot
analysis revealed no significant changes in the protein levels
of the autophagy flux marker p62, indicating that further
studies focused on characterizing the autophagy pathway
in human IR conditions is warranted.
Translational Implications and Limitations
Numerous randomized controlled trials in the oncology
field have evaluated the safety and efficacy of inhibition
or augmentation of autophagy.34 At the experimental level,
relatively nonspecific manipulation of autophagy has been
shown to alter infarct size in coronary ligation models, sug-
gesting the possibility of targeted treatment for human IR
injury.21 Activation of autophagy via pharmacologic means
in a porcine coronary ligation model using the CPY450 in-
hibitor chloramphenicol succinate was associated with
a 6-fold increase in LC3-II expression and 50% reduction
in infarct size.35 Furthermore, a porcine model of ischemic
preconditioning was associated with augmented beclin-1
and LC3-II expression, further supporting the potential ther-
apeutic benefit of autophagy.36 The present findings support
the continued study of global autophagy activation to limit
cardiac failure in response to IR. An alternative strategy
may be to directly manipulate key autophagic machinery-
related molecules such as Foxo, ATG4A, ATG4C, and
ATG4D or regulatory signaling pathways such as the
AMPK-mTOR axis using cell or gene therapy.
The present study has some important limitations. The
gene and protein expression studies provide only a snapshot
of expressionwithout informationon the temporal expression
pattern. Furthermore, we are unable to differentiate the indi-
vidual contributions of ischemia and reperfusion to the over-
all autophagy expression profile. The relatively small sample
size and clinical variability between andwithin thegroupmay
account for some of the inconsistency in the gene expression
profile between the 2 patient cohorts. Indeed, additional
work is needed to confirm our findings and to establish their
respective pathophysiologic and functional significance.E
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TABLE E1. Baseline characteristics and intraoperative details of the
confirmatory patient cohort
N ¼ 7
Age (y) 65.4  16.4
Male 85.7 (6)
Clinical history
Hypertension 85.7 (6)
Dyslipidemia 71.4 (5)
Diabetes 42.9 (3)
Smoking history 28.6 (2)
Heart failure 14.3 (1)
Medications
ACEi/ARB 14.3 (1)
Statin 71.4 (5)
Beta-blocker 42.9 (3)
Calcium channel blocker 28.6 (2)
Surgical procedure
CABG 71.4 (5)
AVR 14.3 (1)
AVR and CABG 14.3 (1)
Degree of Ischemia
CPB (min) 96.0  33.3
Crossclamp/CP (min) 82.9  29.8
Reperfusion (min) 11.4  6.1
Data are presented as n (%) or mean  standard deviation. ACE inhibitor,
Angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker;
CABG, coronary artery bypass graft; AVR, aortic valve replacement; CPB, cardiopul-
monary bypass; CP, cardioplegia.
TABLE E2. Select 14 autophagy genes upregulated or downregulated
as determined by real-time polymerase chain reaction after cardio-
pulmonary bypass/cardioplegia (CPB/CP)
Gene Fold change P value (before vs after CPB/CP)
Caspase-3 1.3 .21
EIF2AK3 1.4 .11
SNCA 1.7 .01
GABARAPL2 2.9 .01
ATG4D 1.4 .92
BCL2L1 1.6 .05
TNFSF10 1.4 .01
GAA 1.3 .21
mTOR 1.6 .01
ATG4B 1.8 .34
ATG4A 1.9 .04
ATG4C 1.5 .03
BAK1 1.2 .61
HSPA8 1.7 .06
CPB, Cardiopulmonary bypass; CP, cardioplegia; EIF2AK3, eukaryotic initiation
factor 2 A kinase; SNCA, a-synuclein; BCL2L1, B-cell lymphocyte 2-like
protein-1; TNFSF10, tumor necrosis factor; GAA, acid-alpha glucosidase;
mTOR, mammalian target of rapamycin; ATG4B, autophagy-related 4B, cysteine pep-
tidase; ATG4A, autophagy-related 4A, cysteine peptidase; ATG4C, autophagy-related
4C, cysteine peptidase; BAK1, B-cell lymphocyte homologous antagonist/killer 1;
GABARAPL2, GABA(A) receptor–associated protein-like 2; HSPA8, heat shock 70
kDa protein 8.
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